Effects of anemia on the survival of patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

References

• Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest. 2000;117:1S–4S.
   PubMed Web of Science ®Google Scholar
• van Zyl Smit RN, Pai M, Yew WW, et al. Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD. Eur Respir J. 2010;35:27–33.
   PubMed Web of Science ®Google Scholar
• López-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21:14–23.
   PubMed Web of Science ®Google Scholar
• Cruz M, Santos M. Epidemiology of chronic obstructive pulmonary disease in Brazil: a systematic review and meta-analysis. Eur Respir J. [Internet]. 2019 [cited 2020 Apr 7];54. Available from https://erj.ersjournals.com/content/54/suppl_63/PA3319
   Web of Science ®Google Scholar
• Raherison C, Girodet P-O. Epidemiology of COPD. Eur Respir Rev. 2009;18:213–221.
   PubMedGoogle Scholar
• Agusti A, Edwards LD, Celli B, et al. Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. Eur Respir J. 2013;42:636–646.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–555.
   PubMed Web of Science ®Google Scholar
• Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004;364:709–721.
   PubMed Web of Science ®Google Scholar
• MacNee W. Pathology, pathogenesis, and pathophysiology. BMJ. 2006;332:1202–1204.
   Web of Science ®Google Scholar
• Han X, Zhang Y. FEV1:FVC thresholds for defining chronic obstructive pulmonary disease. JAMA. 2019;322:1611.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Higuchi K, Yu T-C, et al. Economic burden of COPD in the presence of comorbidities. Chest. 2015;148:138–150.
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Ershler WB. Anemia in COPD: a systematic review of the prevalence, quality of life, and mortality. Respir Care. 2011;56:644–652.
   PubMed Web of Science ®Google Scholar
• Sarkar M, Rajta PN, Khatana J. Anemia in Chronic obstructive pulmonary disease: prevalence, pathogenesis, and potential impact. Lung India. 2015;32:142–151.
   PubMed Web of Science ®Google Scholar
• Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl. 2001;34:50s–9s.
   PubMed Web of Science ®Google Scholar
• Jelkmann W. Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res. 1998;18:555–559.
   PubMed Web of Science ®Google Scholar
• Tassiopoulos S, Kontos A, Konstantopoulos K, et al. Erythropoietic response to hypoxaemia in diffuse idiopathic pulmonary fibrosis, as opposed to chronic obstructive pulmonary disease. Respir Med. 2001;95:471–475.
   PubMed Web of Science ®Google Scholar
• Cloonan SM, Mumby S, Adcock IM, et al. The “Iron”-y of iron overload and iron deficiency in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;196:1103–1112.
   PubMed Web of Science ®Google Scholar
• O’Neill BJ, Marlin GE, Streeter AM. Red-cell macrocytosis in chronic obstructive airway disease. Med J Aust. 1972;1:283.
   PubMed Web of Science ®Google Scholar
• Krishnan G, Grant BJ, Muti PC, et al. Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease. BMC Pulm Med. 2006;6:23.
   PubMedGoogle Scholar
• Miravitlles M, Soriano JB, García-Río F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64:863–868.
   PubMed Web of Science ®Google Scholar
• Boutou AK, Stanopoulos I, Pitsiou GG, et al. Anemia of chronic disease in chronic obstructive pulmonary disease: a case-control study of cardiopulmonary exercise responses. Respiration. 2011;82:237–245.
   PubMed Web of Science ®Google Scholar
• Ferrari M, Manea L, Anton K, et al. Anemia and hemoglobin serum levels are associated with exercise capacity and quality of life in chronic obstructive pulmonary disease. BMC Pulm Med. 2015;15:58.
   PubMed Web of Science ®Google Scholar
• Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J. 2010;35:913–922.
   PubMed Web of Science ®Google Scholar
• Liesker JJW, Postma DS, Beukema RJ, et al. Cognitive performance in patients with COPD. Respir Med. 2004;98:351–356.
   PubMed Web of Science ®Google Scholar
• Ergan B, Ergün R. Impact of anemia on short-term survival in severe COPD exacerbations: a cohort study. Int J Chron Obstruct Pulmon Dis. 2016;11:1775–1783.
   PubMed Web of Science ®Google Scholar
• Miranda Machado PA, Baños Álvarez I, Gaitán Duarte HG. Association between anemia and chronic obstructive pulmonary disease exacerbations in Cartagena Colombia: a prospective cohort study. Medwave. 2019;19:e7602.
   PubMed Web of Science ®Google Scholar
• Oh Y-M, Park JH, Kim E-K, et al. Anemia as a clinical marker of stable chronic obstructive pulmonary disease in the Korean obstructive lung disease cohort. J Thorac Dis. 2017;9:5008–5016.
   PubMed Web of Science ®Google Scholar
• Putcha N, Fawzy A, Paul GG, et al. Anemia and adverse outcomes in a chronic obstructive pulmonary disease population with a high burden of comorbidities. An analysis from SPIROMICS. Ann Am Thorac Soc. 2018;15:710–717.
   PubMed Web of Science ®Google Scholar
• Rahimi-Rad MH, Sadighi T, Rabieepour M, et al. Prevalence of anemia and its impact on mortality in patients with acute exacerbation of chronic obstructive pulmonary disease in a developing country setting. Pneumologia. 2015;64:27–30.
   PubMedGoogle Scholar
• Xiong W, Xu M, Pudasaini B, et al. The influence of anemia on one-year exacerbation rate of patients with COPD-PH. BMC Pulm Med. 2018;18:143.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
   PubMed Web of Science ®Google Scholar
• Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
   PubMed Web of Science ®Google Scholar
• Viswanathan M, Ansari MT, Berkman ND, et al. Assessing the risk of bias of individual studies in systematic reviews of health care interventions. Methods Guide for Effectiveness and Comparative Effectiveness Reviews [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US) 2008; [cited 2020 Mar 7]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK91433/.
   Google Scholar
• Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011;128:305–310.
   PubMed Web of Science ®Google Scholar
• Bax L, Yu L-M, Ikeda N, et al. A systematic comparison of software dedicated to meta-analysis of causal studies. BMC Med Res Methodol. 2007;7:40.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 2009;172:137–159.
   PubMed Web of Science ®Google Scholar
• Rosenthal R. Parametric measures of effect size. The handbook of research synthesis. New York, NY, US: Russell Sage Foundation; 1994. p. 231–244.
   Google Scholar
• Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558.
   PubMed Web of Science ®Google Scholar
• Petitti DB. Approaches to heterogeneity in meta-analysis. Stat Med. 2001;20:3625–3633.
   PubMed Web of Science ®Google Scholar
• Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455–463.
   PubMed Web of Science ®Google Scholar
• Barba R, de Casasola GG, Marco J, et al. Anemia in chronic obstructive pulmonary disease: a readmission prognosis factor. Curr Med Res Opin. 2012;28:617–622.
   PubMed Web of Science ®Google Scholar
• Boutou AK, Karrar S, Hopkinson NS, et al. Anemia and survival in chronic obstructive pulmonary disease: a dichotomous rather than a continuous predictor. Respiration. 2013;85:126–131.
   PubMed Web of Science ®Google Scholar
• Gadre SK, Jhand AS, Abuqayyas S, et al. Effect of anemia on mortality in mechanically ventilated patients with chronic obstructive pulmonary disease. J Intensive Care Med. 2020;35:251–256.
   PubMed Web of Science ®Google Scholar
• Halpern MT, Zilberberg MD, Schmier JK, et al. Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc. 2006;4:17.
   PubMedGoogle Scholar
• Kollert F, Tippelt A, Müller C, et al. Hemoglobin levels above anemia thresholds are maximally predictive for long-term survival in COPD with chronic respiratory failure. Respir Care. 2013;58:1204–1212.
   PubMed Web of Science ®Google Scholar
• Menou A, Pain M, Pivette J, et al. Importance of comorbidities in the anemia of COPD: economic implications and 3-year survival analysis. Rev Mal Respir. 2016;33:565–572.
   PubMed Web of Science ®Google Scholar
• Shorr AF, Doyle J, Stern L, et al. Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications. Curr Med Res Opin. 2008;24:1123–1130.
   PubMed Web of Science ®Google Scholar
• Toft-Petersen AP, Torp-Pedersen C, Weinreich UM, et al. Association between hemoglobin and prognosis in patients admitted to hospital for COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2813–2820.
   PubMed Web of Science ®Google Scholar
• Cote C, Zilberberg MD, Mody SH, et al. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J. 2007;29:923–929.
   PubMed Web of Science ®Google Scholar
• Calverley P, Bellamy D. The challenge of providing better care for patients with chronic obstructive pulmonary disease: the poor relation of airways obstruction? Thorax. 2000;55:78–82.
   PubMed Web of Science ®Google Scholar
• Gustafsson T, Nordeman L. The nurse’s challenge of caring for patients with chronic obstructive pulmonary disease in primary health care. Nurs Open. 2018;5:292–299.
   PubMed Web of Science ®Google Scholar
• Shengda Song LG. The cardiomyopathy of iron deficiency anaemia. EMJ Cardiol. 2018;6:92–98.
   Google Scholar
• Foley RN, Parfrey PS, Harnett JD, et al. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis. 1996;28:53–61.
   PubMed Web of Science ®Google Scholar
• Hegde N, Rich MW, Gayomali C. The cardiomyopathy of iron deficiency. Tex Heart Inst J. 2006;33:340–344.
   PubMed Web of Science ®Google Scholar
• Yokusoglu M, Nevruz O, Baysan O, et al. The altered autonomic nervous system activity in iron deficiency anemia. Tohoku J Exp Med. 2007;212:397–402.
   PubMed Web of Science ®Google Scholar
• Naito Y, Tsujino T, Matsumoto M, et al. Adaptive response of the heart to long-term anemia induced by iron deficiency. Am J Physiol Heart Circ Physiol. 2009;296:H585–593.
   PubMed Web of Science ®Google Scholar
• Amaral AFS, Anselmo H, da Cunha RMPTT, et al. The connective tissue index of Helix aspersa as a metal biomarker. Biometals. 2004;17:625–629.
   PubMed Web of Science ®Google Scholar
• de Hoepers ATC, Menezes MM, Fröde TS. Systematic review of anaemia and inflammatory markers in chronic obstructive pulmonary disease. Clin Exp Pharmacol Physiol. 2015;42:231–239.
   PubMed Web of Science ®Google Scholar
• Boutou AK, Pitsiou GG, Stanopoulos I, et al. Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study. QJM. 2012;105:657–663.
   PubMed Web of Science ®Google Scholar
• Feteh VF, Choukem S-P, Kengne A-P, et al. Anemia in type 2 diabetic patients and correlation with kidney function in a tertiary care sub-Saharan African hospital: a cross-sectional study. BMC Nephrol. 2016;17:29.
   PubMed Web of Science ®Google Scholar
• Singanayagam A, Schembri S, Chalmers JD. Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2013;10:81–89.
   PubMedGoogle Scholar
• Markoulaki D, Kostikas K, Papatheodorou G, et al. Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease. Eur J Intern Med. 2011;22:103–107.
   PubMed Web of Science ®Google Scholar
• PLoS Medicine Editors. Best practice in systematic reviews: the importance of protocols and registration. PLoS Med. 2011;8:e1001009.
   PubMed Web of Science ®Google Scholar